Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.7 USD | +2.21% | +15.69% | +112.43% |
May. 14 | Taysha Gene Therapies Q1 Net Loss Narrows, Revenue Declines -- Shares Down After Hours | MT |
May. 14 | Transcript : Taysha Gene Therapies, Inc., Q1 2024 Earnings Call, May 14, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+112.43% | 677M | |
+43.87% | 56.65B | |
-6.89% | 39.44B | |
+38.87% | 39.03B | |
-11.17% | 26.86B | |
+13.06% | 26.75B | |
-21.12% | 19.03B | |
+1.37% | 12.28B | |
+26.42% | 12.26B | |
+27.83% | 12.04B |
- Stock Market
- Equities
- TSHA Stock
- News Taysha Gene Therapies, Inc.
- Truist Securities Raises Price Target on Taysha Gene Therapies to $6 From $2, Maintains Buy Rating